HIGHLIGHTS
- who: Darya A. Kuznetsova et al. from the Arbuzov Institute of Organic and Physical Chemistry, FRC Kazan Scientific Center, Russian Academy of Sciences have published the paper: Oxime Therapy for Brain AChE Reactivation and Neuroprotection after Organophosphate Poisoning, in the Journal: Pharmaceutics 2022, 1950 of /2022/
- what: In this work modified cationic liposomes were developed that can penetrate through the BBB and deliver the reactivator of AChE pralidoxime chloride (2-PAM) into the brain. The aim of this study was to create new cationic liposomes loaded with 2-PAM to overcome the BBB, with a . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.